Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
Holding AVIR?
Track your performance easily

Atea Pharmaceuticals (AVIR) Financial Statements

208 Followers

Atea Pharmaceuticals Financial Overview

Atea Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.072; its P/E ratio is -1.69; Atea Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -30.93M$ -40.28M$ -69.81M-$ -40.78M
EBITDA$ -30.82M$ -36.69M$ -69.70M-$ -40.68M
Net Income Common Stockholders$ -31.15M$ -40.52M$ -63.17M$ -39.16M$ -33.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 482.81M$ 502.21M$ 541.49M$ 578.11M$ 595.13M
Total Assets$ 490.96M$ 510.38M$ 553.03M$ 594.97M$ 608.08M
Total Debt$ 1.83M$ 2.02M$ 2.21M$ 2.40M$ 2.58M
Net Debt$ -480.98M$ -500.19M$ -539.28M$ -575.70M$ -592.54M
Total Liabilities$ 32.44M$ 33.91M$ 48.66M$ 39.78M$ 26.34M
Stockholders Equity$ 458.52M$ 476.47M$ 504.37M$ 555.19M$ 581.73M
Cash Flow-
Free Cash Flow$ -23.04M$ -42.20M$ -39.87M-$ -17.59M
Operating Cash Flow$ -23.04M$ -42.20M$ -39.87M$ -21.83M$ -17.59M
Investing Cash Flow$ -122.01M$ 124.69M$ 56.80M$ 27.77M$ -58.51M
Financing Cash Flow$ 117.00K-$ 150.00K-$ 92.00K
Currency in USD

Atea Pharmaceuticals Earnings and Revenue History

Atea Pharmaceuticals Debt to Assets

Atea Pharmaceuticals Cash Flow

Atea Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis